rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael P. Stansky

Director

Company insider

Files Form 4 as: Director, TriSalus Life Sciences; Director, MAKO Surgical.

In numbers

Trades disclosed
25
Buys
3
Sells
0
Bought
$8.5M
Sold
$0
Companies
2
Companies where not an officer
2
First trade
20 Feb 2008
Last trade
15 May 2026
Last filed
18 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TLSI TriSalus Life SciencesDirector · Medical Devices · last 15 May 20262 buys · 0 sells
MAKO SurgicalDirector · last 20 Feb 20081 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 May 2026filed 18 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$1.0M410,000 at $2.50filing
15 May 2026filed 18 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$500K200,000 at $2.50filing
15 May 2026filed 18 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$1.0M410,000 at $2.50filing
15 May 2026filed 18 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$500K200,000 at $2.50filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—23,501 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—20,089 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—47,003 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—47,003 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—23,501 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—20,089 at $0.00filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$1000K243,900 at $4.10filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$481K117,198 at $4.10filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$1000K243,900 at $4.10filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$481K117,198 at $4.10filing
4 Feb 2026filed 11 Feb 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—92,537 at $0.00filing
4 Feb 2026filed 11 Feb 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—92,537 at $0.00filing
20 Feb 2008filed 22 Feb 2008MAKO Surgicaloption or derivativeSEC FORM 4 Code C—9,862 at $0.00filing
20 Feb 2008filed 22 Feb 2008MAKO Surgicaloption or derivativeSEC FORM 4 Code C—1,107,917 at $0.00filing
20 Feb 2008filed 22 Feb 2008MAKO Surgicaloption or derivativeSEC FORM 4 Code C—368,855 at $0.00filing
20 Feb 2008filed 22 Feb 2008MAKO SurgicalSEC FORM 4 Code C—9,862filing

Sectors

Health Care2
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Richard MarshakChief Commercial Officer · Chief Commercial Officer at TriSalus Life Sciences, filing Form 4 there in the last year
Mary T. SzelaCEO and President · CEO and President at TriSalus Life Sciences, filing Form 4 there in the last year
Jennifer StevensChief Regulatory Officer · Chief Regulatory Officer at TriSalus Life Sciences, filing Form 4 there in the last year
Bryan F. CoxChief of Research · Chief of Research at TriSalus Life Sciences, filing Form 4 there in the last year
David PatienceChief Financial Officer · Chief Financial Officer at TriSalus Life Sciences, filing Form 4 there in the last year